Advertisement

Topics

Pfizer, Astellas prostate cancer drug promising in late-stage trial

13:10 EDT 14 Sep 2017 | Topix

Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for treating the disease in its early stages. The positive data sets the stage for an earlier-than-expected approval of the drug, which is already cleared to treat metastatic castration-resistant prostate cancer - where the cancer has spread to other parts of the body.

Original Article: Pfizer, Astellas prostate cancer drug promising in late-stage trial

NEXT ARTICLE

More From BioPortfolio on "Pfizer, Astellas prostate cancer drug promising in late-stage trial"

Quick Search
Advertisement